Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$101.21 - $166.61 $25,504 - $41,985
-252 Reduced 7.31%
3,193 $379 Million
Q1 2024

Apr 22, 2024

BUY
$85.37 - $115.44 $294,099 - $397,690
3,445 New
3,445 $367 Million
Q3 2023

Nov 06, 2023

SELL
$96.41 - $126.61 $156,087 - $204,981
-1,619 Reduced 36.94%
2,764 $285 Million
Q2 2023

Aug 03, 2023

BUY
$118.5 - $160.53 $10,783 - $14,608
91 Added 2.12%
4,383 $533 Million
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $582,252 - $845,609
4,292 New
4,292 $659 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.